Cite
HARVARD Citation
Fraser, G. et al. (2019). The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study. Maturitas. pp. 135-. [Online].